| fatty acid beta oxidation | GO:0006635 | 1 | 0.840 | |
| organic acid catabolic process | GO:0016054 | 3 | 0.800 | |
| carboxylic acid catabolic process | GO:0046395 | 3 | 0.596 | |
| cellular respiration | GO:0045333 | 3 | 0.304 | |
| larval development | GO:0002164 | 2 | 0.287 | |
| monocarboxylic acid catabolic process | GO:0072329 | 3 | 0.279 | |
| fatty acid catabolic process | GO:0009062 | 1 | 0.260 | |
| cellular lipid catabolic process | GO:0044242 | 3 | 0.236 | |
| lipid catabolic process | GO:0016042 | 4 | 0.200 | |
| small molecule metabolic process | GO:0044281 | 77 | 0.198 | |
| electron transport chain | GO:0022900 | 2 | 0.160 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 271 | 0.131 | |
| lipid oxidation | GO:0034440 | 1 | 0.129 | |
| oxoacid metabolic process | GO:0043436 | 31 | 0.092 | |
| response to drug | GO:0042493 | 3 | 0.085 | |
| carboxylic acid metabolic process | GO:0019752 | 22 | 0.076 | |
| aging | GO:0007568 | 2 | 0.074 | |
| single organism metabolic process | GO:0044710 | 217 | 0.063 | |
| response to chemical | GO:0042221 | 320 | 0.062 | Human |
| organonitrogen compound metabolic process | GO:1901564 | 74 | 0.052 | |
| response to glucocorticoid | GO:0051384 | 1 | 0.052 | |
| response to corticosteroid | GO:0031960 | 1 | 0.052 | |
| protein homooligomerization | GO:0051260 | 3 | 0.051 | |
| organic acid metabolic process | GO:0006082 | 31 | 0.050 | |
| cellular catabolic process | GO:0044248 | 27 | 0.049 | |
| cellular component biogenesis | GO:0044085 | 178 | 0.047 | |
| atp catabolic process | GO:0006200 | 4 | 0.045 | |
| female sex differentiation | GO:0046660 | 4 | 0.045 | |
| fatty acid oxidation | GO:0019395 | 1 | 0.045 | |
| respiratory electron transport chain | GO:0022904 | 2 | 0.044 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 4 | 0.044 | |
| cellular component morphogenesis | GO:0032989 | 336 | 0.043 | |
| carbohydrate derivative metabolic process | GO:1901135 | 61 | 0.042 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 4 | 0.042 | |
| maintenance of location | GO:0051235 | 4 | 0.039 | |
| mitochondrion organization | GO:0007005 | 4 | 0.038 | Human |
| response to stress | GO:0006950 | 263 | 0.036 | Human |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 4 | 0.035 | |
| neuron differentiation | GO:0030182 | 353 | 0.035 | |
| cell morphogenesis | GO:0000902 | 289 | 0.035 | |
| response to nutrient | GO:0007584 | 3 | 0.034 | |
| cellular response to external stimulus | GO:0071496 | 2 | 0.033 | |
| small molecule catabolic process | GO:0044282 | 3 | 0.032 | |
| phagocytosis | GO:0006909 | 3 | 0.031 | |
| cellular lipid metabolic process | GO:0044255 | 36 | 0.030 | |
| cell projection organization | GO:0030030 | 284 | 0.030 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 4 | 0.030 | |
| regulation of signal transduction | GO:0009966 | 225 | 0.029 | Human |
| cell aging | GO:0007569 | 2 | 0.029 | |
| lipid storage | GO:0019915 | 1 | 0.029 | |
| positive regulation of transport | GO:0051050 | 2 | 0.028 | |
| oxidation reduction process | GO:0055114 | 41 | 0.028 | |
| response to uv | GO:0009411 | 3 | 0.028 | |
| biosynthetic process | GO:0009058 | 294 | 0.028 | |
| nitrogen compound metabolic process | GO:0006807 | 319 | 0.027 | |
| mitochondrion morphogenesis | GO:0070584 | 2 | 0.027 | |
| stem cell maintenance | GO:0019827 | 4 | 0.027 | |
| response to cold | GO:0009409 | 4 | 0.026 | |
| female gonad development | GO:0008585 | 4 | 0.026 | |
| gastrulation | GO:0007369 | 208 | 0.026 | |
| cellular macromolecule metabolic process | GO:0044260 | 391 | 0.026 | |
| locomotion | GO:0040011 | 313 | 0.026 | |
| cellular amino acid metabolic process | GO:0006520 | 7 | 0.026 | |
| response to external stimulus | GO:0009605 | 264 | 0.026 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 163 | 0.025 | |
| regulation of cell shape | GO:0008360 | 1 | 0.025 | |
| estrogen metabolic process | GO:0008210 | 2 | 0.025 | |
| response to topologically incorrect protein | GO:0035966 | 2 | 0.025 | |
| negative regulation of cellular process | GO:0048523 | 283 | 0.025 | Human |
| compound eye development | GO:0048749 | 2 | 0.025 | |
| neuron development | GO:0048666 | 262 | 0.025 | |
| generation of neurons | GO:0048699 | 385 | 0.024 | |
| multicellular organism growth | GO:0035264 | 4 | 0.024 | |
| cell part morphogenesis | GO:0032990 | 246 | 0.024 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 3 | 0.024 | |
| cell projection morphogenesis | GO:0048858 | 244 | 0.024 | |
| phosphorus metabolic process | GO:0006793 | 109 | 0.023 | |
| regulation of multicellular organism growth | GO:0040014 | 4 | 0.023 | |
| regulation of macromolecule metabolic process | GO:0060255 | 317 | 0.023 | |
| cellular nitrogen compound biosynthetic process | GO:0044271 | 218 | 0.023 | |
| establishment of protein localization to organelle | GO:0072594 | 4 | 0.023 | |
| development of primary female sexual characteristics | GO:0046545 | 4 | 0.023 | |
| protein import | GO:0017038 | 3 | 0.023 | |
| protein targeting to nucleus | GO:0044744 | 3 | 0.022 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 2 | 0.022 | |
| signal transduction | GO:0007165 | 455 | 0.022 | Human |
| lipid metabolic process | GO:0006629 | 52 | 0.022 | |
| cell substrate adhesion | GO:0031589 | 4 | 0.022 | |
| regulation of primary metabolic process | GO:0080090 | 311 | 0.021 | |
| digestive system development | GO:0055123 | 289 | 0.021 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 2 | 0.020 | |
| proteasomal protein catabolic process | GO:0010498 | 2 | 0.020 | |
| heart development | GO:0007507 | 313 | 0.020 | |
| regulation of biological quality | GO:0065008 | 263 | 0.020 | Human |
| phosphatidylinositol mediated signaling | GO:0048015 | 2 | 0.020 | |
| response to organic substance | GO:0010033 | 153 | 0.020 | |
| system process | GO:0003008 | 185 | 0.019 | |
| blood vessel morphogenesis | GO:0048514 | 216 | 0.019 | |
| cellular response to extracellular stimulus | GO:0031668 | 2 | 0.019 | |
| very long chain fatty acid metabolic process | GO:0000038 | 4 | 0.019 | |
| response to transition metal nanoparticle | GO:1990267 | 28 | 0.019 | |
| regulation of reproductive process | GO:2000241 | 4 | 0.019 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 195 | 0.019 | |
| positive regulation of map kinase activity | GO:0043406 | 3 | 0.019 | |
| cellular ketone metabolic process | GO:0042180 | 11 | 0.019 | |
| gland development | GO:0048732 | 143 | 0.019 | |
| negative regulation of kinase activity | GO:0033673 | 4 | 0.018 | |
| cellular component assembly | GO:0022607 | 170 | 0.018 | |
| cellular response to stress | GO:0033554 | 62 | 0.018 | Human |
| modification dependent macromolecule catabolic process | GO:0043632 | 3 | 0.018 | |
| cellular nitrogen compound metabolic process | GO:0034641 | 290 | 0.018 | |
| inositol lipid mediated signaling | GO:0048017 | 2 | 0.017 | |
| response to endogenous stimulus | GO:0009719 | 83 | 0.017 | |
| regulation of epithelial cell proliferation | GO:0050678 | 3 | 0.017 | |
| nuclear import | GO:0051170 | 3 | 0.017 | |
| regulation of binding | GO:0051098 | 3 | 0.017 | |
| cellular response to chemical stimulus | GO:0070887 | 157 | 0.017 | Human |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 1 | 0.017 | |
| regulation of nucleoside metabolic process | GO:0009118 | 2 | 0.017 | |
| negative regulation of biological process | GO:0048519 | 304 | 0.016 | Human |
| ovulation cycle | GO:0042698 | 2 | 0.016 | |
| protein import into nucleus | GO:0006606 | 3 | 0.016 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 2 | 0.016 | |
| single organism localization | GO:1902578 | 225 | 0.016 | Human |
| generation of precursor metabolites and energy | GO:0006091 | 5 | 0.016 | |
| regulation of signaling | GO:0023051 | 235 | 0.016 | Human |
| positive regulation of catabolic process | GO:0009896 | 4 | 0.016 | |
| tube morphogenesis | GO:0035239 | 349 | 0.016 | |
| cellular modified amino acid metabolic process | GO:0006575 | 3 | 0.016 | |
| striated muscle tissue development | GO:0014706 | 110 | 0.016 | |
| cellular response to decreased oxygen levels | GO:0036294 | 1 | 0.016 | Human |
| positive regulation of cell cycle | GO:0045787 | 3 | 0.016 | |
| cell death in response to oxidative stress | GO:0036473 | 2 | 0.016 | |
| cellular response to topologically incorrect protein | GO:0035967 | 2 | 0.016 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 3 | 0.015 | |
| regulation of cytoplasmic transport | GO:1903649 | 4 | 0.015 | |
| heterocycle metabolic process | GO:0046483 | 290 | 0.015 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 191 | 0.015 | |
| single organism nuclear import | GO:1902593 | 3 | 0.015 | |
| regulation of muscle contraction | GO:0006937 | 3 | 0.015 | |
| positive regulation of blood circulation | GO:1903524 | 2 | 0.015 | |
| cellular amine metabolic process | GO:0044106 | 2 | 0.015 | |
| neuron projection development | GO:0031175 | 180 | 0.015 | |
| morphogenesis of an epithelium | GO:0002009 | 333 | 0.015 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 0 | 0.015 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 2 | 0.015 | |
| regulation of autophagy | GO:0010506 | 3 | 0.015 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 3 | 0.015 | |
| regulation of cellular biosynthetic process | GO:0031326 | 245 | 0.015 | |
| regulation of cell substrate adhesion | GO:0010810 | 1 | 0.014 | |
| establishment of localization | GO:0051234 | 244 | 0.014 | Human |
| regulation of blood pressure | GO:0008217 | 1 | 0.014 | |
| regulation of tube size | GO:0035150 | 2 | 0.014 | |
| apoptotic process involved in development | GO:1902742 | 2 | 0.014 | |
| regulation of sequestering of calcium ion | GO:0051282 | 4 | 0.014 | |
| positive regulation of dna metabolic process | GO:0051054 | 1 | 0.014 | |
| negative regulation of reproductive process | GO:2000242 | 3 | 0.014 | |
| secondary metabolic process | GO:0019748 | 3 | 0.014 | |
| cellular component movement | GO:0006928 | 335 | 0.014 | |
| cellular biosynthetic process | GO:0044249 | 286 | 0.014 | |
| nucleocytoplasmic transport | GO:0006913 | 4 | 0.014 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 43 | 0.014 | |
| nephron morphogenesis | GO:0072028 | 2 | 0.014 | |
| response to abiotic stimulus | GO:0009628 | 122 | 0.014 | Human |
| germ line stem cell maintenance | GO:0030718 | 2 | 0.014 | |
| cytokinesis | GO:0000910 | 3 | 0.014 | |
| regulation of meiotic cell cycle | GO:0051445 | 1 | 0.014 | |
| muscle structure development | GO:0061061 | 196 | 0.014 | |
| dicarboxylic acid metabolic process | GO:0043648 | 1 | 0.014 | |
| regulation of multicellular organismal development | GO:2000026 | 223 | 0.014 | |
| synaptic growth at neuromuscular junction | GO:0051124 | 2 | 0.013 | |
| cellular protein catabolic process | GO:0044257 | 4 | 0.013 | |
| protein metabolic process | GO:0019538 | 183 | 0.013 | |
| immune system process | GO:0002376 | 241 | 0.013 | |
| nuclear transport | GO:0051169 | 4 | 0.013 | |
| regulation of developmental process | GO:0050793 | 247 | 0.013 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 1 | 0.013 | |
| primary neural tube formation | GO:0014020 | 1 | 0.013 | |
| protein localization to nucleus | GO:0034504 | 3 | 0.013 | |
| establishment of synaptic vesicle localization | GO:0097480 | 1 | 0.013 | |
| regulation of cell activation | GO:0050865 | 1 | 0.013 | |
| cellular response to oxygen levels | GO:0071453 | 1 | 0.013 | Human |
| negative regulation of nuclear division | GO:0051784 | 3 | 0.013 | |
| developmental growth | GO:0048589 | 166 | 0.013 | |
| regulation of blood vessel size | GO:0050880 | 2 | 0.013 | |
| regulation of membrane potential | GO:0042391 | 23 | 0.013 | |
| signal transduction in absence of ligand | GO:0038034 | 1 | 0.013 | |
| monocarboxylic acid metabolic process | GO:0032787 | 17 | 0.013 | |
| developmental programmed cell death | GO:0010623 | 4 | 0.013 | |
| reactive oxygen species metabolic process | GO:0072593 | 6 | 0.013 | |
| regulation of protein transport | GO:0051223 | 3 | 0.013 | |
| regulation of metal ion transport | GO:0010959 | 4 | 0.013 | |
| negative regulation of intracellular transport | GO:0032387 | 3 | 0.013 | Human |
| amine metabolic process | GO:0009308 | 2 | 0.013 | |
| phosphate containing compound metabolic process | GO:0006796 | 108 | 0.013 | |
| tissue remodeling | GO:0048771 | 4 | 0.013 | |
| gtp catabolic process | GO:0006184 | 2 | 0.013 | |
| response to starvation | GO:0042594 | 5 | 0.013 | |
| eye development | GO:0001654 | 277 | 0.012 | |
| axon development | GO:0061564 | 166 | 0.012 | |
| rna localization | GO:0006403 | 4 | 0.012 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 1 | 0.012 | |
| regulation of macromolecule biosynthetic process | GO:0010556 | 225 | 0.012 | |
| atp synthesis coupled electron transport | GO:0042773 | 1 | 0.012 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 7 | 0.012 | |
| branching morphogenesis of a nerve | GO:0048755 | 4 | 0.012 | |
| regulation of response to extracellular stimulus | GO:0032104 | 1 | 0.012 | |
| dna templated transcription elongation | GO:0006354 | 3 | 0.012 | |
| organelle organization | GO:0006996 | 227 | 0.012 | Human |
| axonogenesis | GO:0007409 | 152 | 0.012 | |
| regulation of calcium ion transport | GO:0051924 | 2 | 0.012 | |
| regulation of biosynthetic process | GO:0009889 | 250 | 0.012 | |
| negative regulation of programmed cell death | GO:0043069 | 58 | 0.012 | Human |
| angiogenesis | GO:0001525 | 158 | 0.012 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 4 | 0.012 | |
| er nucleus signaling pathway | GO:0006984 | 2 | 0.012 | |
| positive regulation of canonical wnt signaling pathway | GO:0090263 | 4 | 0.012 | |
| organic cyclic compound metabolic process | GO:1901360 | 301 | 0.012 | |
| negative regulation of signal transduction | GO:0009968 | 94 | 0.012 | Human |
| positive regulation of cytokine production | GO:0001819 | 2 | 0.012 | |
| somatic muscle development | GO:0007525 | 4 | 0.012 | |
| macromolecule biosynthetic process | GO:0009059 | 227 | 0.012 | |
| regulation of cytokine production | GO:0001817 | 3 | 0.012 | |
| acyl coa metabolic process | GO:0006637 | 1 | 0.012 | |
| transcription dna templated | GO:0006351 | 181 | 0.012 | |
| camera type eye development | GO:0043010 | 222 | 0.012 | |
| mesenchymal cell proliferation | GO:0010463 | 1 | 0.012 | |
| regulation of nucleotide catabolic process | GO:0030811 | 2 | 0.012 | |
| rna biosynthetic process | GO:0032774 | 181 | 0.012 | |
| regulation of synapse assembly | GO:0051963 | 3 | 0.012 | |
| intracellular signal transduction | GO:0035556 | 85 | 0.012 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 1 | 0.012 | |
| sequestering of metal ion | GO:0051238 | 3 | 0.012 | |
| spermatid differentiation | GO:0048515 | 2 | 0.012 | |
| zymogen activation | GO:0031638 | 3 | 0.012 | |
| positive regulation of immune effector process | GO:0002699 | 3 | 0.012 | |
| organelle fusion | GO:0048284 | 3 | 0.012 | |
| regulation of cellular metabolic process | GO:0031323 | 320 | 0.012 | |
| sequestering of calcium ion | GO:0051208 | 3 | 0.012 | |
| organic substance biosynthetic process | GO:1901576 | 289 | 0.012 | |
| muscle cell differentiation | GO:0042692 | 139 | 0.012 | |
| regulation of protein import into nucleus | GO:0042306 | 2 | 0.011 | |
| cellular response to starvation | GO:0009267 | 1 | 0.011 | |
| positive regulation of cell adhesion | GO:0045785 | 1 | 0.011 | |
| regulation of establishment of protein localization | GO:0070201 | 4 | 0.011 | |
| modification dependent protein catabolic process | GO:0019941 | 3 | 0.011 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 0 | 0.011 | |
| cellular aromatic compound metabolic process | GO:0006725 | 295 | 0.011 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 0 | 0.011 | |
| regulation of protein catabolic process | GO:0042176 | 1 | 0.011 | |
| gene expression | GO:0010467 | 252 | 0.011 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.011 | |
| positive regulation of cellular catabolic process | GO:0031331 | 3 | 0.011 | |
| head development | GO:0060322 | 303 | 0.011 | |
| regulation of nucleic acid templated transcription | GO:1903506 | 213 | 0.011 | |
| alpha amino acid metabolic process | GO:1901605 | 3 | 0.011 | |
| negative regulation of cell communication | GO:0010648 | 96 | 0.011 | Human |
| locomotor rhythm | GO:0045475 | 3 | 0.011 | |
| regulation of intracellular protein transport | GO:0033157 | 3 | 0.011 | |
| cytoplasm organization | GO:0007028 | 4 | 0.011 | |
| regulation of mrna processing | GO:0050684 | 3 | 0.011 | |
| transmission of nerve impulse | GO:0019226 | 19 | 0.011 | |
| thioester metabolic process | GO:0035383 | 1 | 0.011 | |
| long chain fatty acid metabolic process | GO:0001676 | 1 | 0.011 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 1 | 0.011 | |
| cellular hormone metabolic process | GO:0034754 | 19 | 0.011 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 3 | 0.011 | |
| regulation of skeletal muscle tissue development | GO:0048641 | 4 | 0.011 | |
| protein polyubiquitination | GO:0000209 | 4 | 0.011 | |
| nucleobase containing compound metabolic process | GO:0006139 | 274 | 0.011 | |
| ras protein signal transduction | GO:0007265 | 7 | 0.011 | |
| cellular response to nutrient levels | GO:0031669 | 2 | 0.011 | |
| nucleobase containing compound biosynthetic process | GO:0034654 | 205 | 0.011 | |
| b cell differentiation | GO:0030183 | 1 | 0.011 | |
| protein stabilization | GO:0050821 | 2 | 0.011 | |
| calcium mediated signaling | GO:0019722 | 2 | 0.011 | |
| epithelial cell morphogenesis | GO:0003382 | 2 | 0.011 | |
| negative chemotaxis | GO:0050919 | 1 | 0.011 | |
| brain development | GO:0007420 | 293 | 0.011 | |
| regulation of rho protein signal transduction | GO:0035023 | 2 | 0.011 | |
| ovarian follicle development | GO:0001541 | 2 | 0.011 | |
| gtp metabolic process | GO:0046039 | 4 | 0.011 | |
| leukocyte proliferation | GO:0070661 | 1 | 0.010 | |
| negative regulation of response to stimulus | GO:0048585 | 104 | 0.010 | Human |
| regulation of mrna splicing via spliceosome | GO:0048024 | 3 | 0.010 | |
| action potential | GO:0001508 | 19 | 0.010 | |
| activation of mapk activity | GO:0000187 | 3 | 0.010 | |
| negative regulation of catabolic process | GO:0009895 | 3 | 0.010 | |
| multicellular organismal response to stress | GO:0033555 | 2 | 0.010 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 3 | 0.010 | |
| nucleic acid metabolic process | GO:0090304 | 244 | 0.010 | |
| energy reserve metabolic process | GO:0006112 | 2 | 0.010 | |
| vasculature development | GO:0001944 | 278 | 0.010 | |
| digestive tract development | GO:0048565 | 265 | 0.010 | |
| adult behavior | GO:0030534 | 2 | 0.010 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 1 | 0.010 | |
| regulation of protein localization to nucleus | GO:1900180 | 2 | 0.010 | |
| regulation of gtpase activity | GO:0043087 | 2 | 0.010 | |
| regulation of protein targeting | GO:1903533 | 2 | 0.010 | |
| negative regulation of protein phosphorylation | GO:0001933 | 4 | 0.010 | |
